Influence of a new 5-HT4 receptor partial agonist, YKP10811, on visceral hypersensitivity in rats triggered by stress and inflammation

Neurogastroenterology and Motility

Volumn 26, Issue 12, 2014, Pages 1761-1770

  Gilet, M ^a   Eutamene, H ^a   Han, H ^b   Kim, H W ^b   Bueno, L ^a  

^a CEMAGREF   (France)

^b SK life science   (United States)

Author keywords

5 HT4 receptors; Colorectal distension; Serotonin; Stress; Visceral pain; YKP10811

Indexed keywords

BENZAMIDE DERIVATIVE; CARBAMIC ACID 3-(4-((4-AMINO-5-CHLORO-2-METHOXYBENZOYLAMINO)METHYL)PIPERIDIN-1-YL)-1-(4-FLUOROPHENYL)PROPYL ESTER; CARBAMIC ACID DERIVATIVE; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST;

ANIMAL; COLON; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; HYPERALGESIA; INFLAMMATION; MALE; MANOMETRY; MENTAL STRESS; PATHOPHYSIOLOGY; RAT; VISCERAL PAIN; WISTAR RAT;

ANIMALS; BENZAMIDES; CARBAMATES; COLON; DISEASE MODELS, ANIMAL; FEMALE; HYPERALGESIA; INFLAMMATION; MALE; MANOMETRY; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN RECEPTOR AGONISTS; STRESS, PSYCHOLOGICAL; VISCERAL PAIN;

EID: 84911466833     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12458     Document Type: Article

References (37)

1. De Giorgio R, Barbara G, Furness JB, Tonini M. Novel therapeutic targets for enteric nervous system disorders. Trends Pharmacol Sci 2007; 28: 473-81.
2. Gershon MD. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004; 20(Suppl. 7): 3-14 Review.
3. Hoffman JM, Tyler K, MacEachern SJ, Balemba OB, Johnson AC, Brooks EM, Zhao H, Swain GM et al. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology 2012; 142: 844-854.e4.
4. Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 1989; 96: 1257-64.
5. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115: 370-80.
6. 3 receptors. J Pharmacol Exp Ther 1999; 288: 93-7.
7. Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterol Motil 2006; 18: 76-86.
8. Choung RS, Locke GR 3rd, Schleck CD, Zinsmeister AR, Talley NJ. Cumulative incidence of chronic constipation: a population-based study 1988-2003. Aliment Pharmacol Ther 2007; 26: 1521-8.
9. Johanson JF, Sonnenberg A, Koch TR. Clinical epidemiology of chronic constipation. J Clin Gastroenterol 1989; 11: 525-36 Review.
10. Briejer MR, Schuurkes JA, Sarna SK. Idiopathic constipation: too few stools and too little knowledge. Trends Pharmacol Sci 1999; 20: 1-3 Review.
11. Bassotti G, Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol 2006; 12: 4609-13 Review.
12. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34-43.
13. Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology 2013; 145: 749-57.
14. Colucci R, Blandizzi C, Bellini M, Ghisu N, Tonini M, Del Tacca M. Trends Mol Med 2008; 14: 295-304.
15. Areeshi MY, Haque S, Panda AK, Mandal RK. A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis. PLoS ONE 2013; 8: e75567.
16. 4receptor selective agonists, velusetrag and TD-8954. Vascul Pharmacol 2013; 58: 150-6.
17. Racké K, Reimann A, Schwörer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996; 73: 83-7 Review.
18. Morteau O, Hachet T, Caussette M, Bueno L. Experimental colitis alters visceromotor response to colorectal distension in awake rats. Dig Dis Sci 1994; 39: 1239-48.
19. Gué M, Del Rio-Lacheze C, Eutamene H, Théodorou V, Fioramonti J, Buéno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil 1997; 9: 271-9.
20. Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA et al. Repeated exposure to water avoidance stress in rats: a new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol 2005; 289: G42-53.
21. Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009; 104: 1831-43.
22. Emmanuel AV, Kamm MA, Roy AJ, Kerstens R, Vandeplassche L. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction-a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther 2012; 35: 48-55.
23. Kidd M, Modlin IM, Eick GN, Champaneria MC. Isolation, functional characterization, and transcriptome of Mastomys ileal enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 2006; 291: G778-91.
24. Ning Y, Zhu JX, Chan HC. Regulation of ion transport by 5-hydroxytryptamine in rat colon. Clin Exp Pharmacol Physiol 2004; 31: 424-8.
25. Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial. Am J Gastroenterol 2008; 103: 1217-25.
26. Coelho A-M, Rovira P, Fioramonti J, Bueno L. Antinociceptive properties of HTF 919 (tegaserod) a 5-HT4 receptor partial agonist on colorectal distension in rats. Gastroenterology 2000; 218: A835.
27. Schikowski A, Thewissen M, Mathis C, Ross HG, Enck P. Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum. Neurogastroenterol Motil 2002; 14: 221-7.
28. Greenwood-Van Meerveld B, Campbell-Dittmeyer K, Johnson AC, Hicks GA. 5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity. Neurogastroenterol Motil 2006; 18: 343-5.
29. 2B receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction. Neurogastroenterol Motil 2010; 22: 573-8.
30. 2B receptor antagonist in vitro and in vivo. Br J Pharmacol 2004; 143: 549-60.
31. Yang PC, Jury J, Söderholm JD, Sherman PM, McKay DM, Perdue MH. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol 2006; 168: 104-14.
32. Tonini M, Pace F. Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig Dis 2006; 24: 59-69 Review.
33. Contesse V, Lefebvre H, Lenglet S, Kuhn JM, Delarue C, Vaudry H. Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells. Can J Physiol Pharmacol 2000; 78: 967-83.
34. De Maeyer JH, Prins NH, Schuurkes JA, Lefebvre RA. Differential effects of 5-hydroxytryptamine 4 receptor agonists at gastric versus cardiac receptors: an operational framework to explain and quantify organ-specific behavior. J Pharmacol Exp Ther 2006; 317: 955-64.
35. 4 receptor-mediated response in pig atrium but not in stomach. Br J Pharmacol 2009; 156: 362-76.
36. Coupar IM, Irving HR, Manallack DT, Tan YY, Ayad F, Iulio JD, Tochon-Danguy N, Iskander MN. Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors. J Pharm Pharmacol 2012; 64: 1099-106.
37. Russo O, Berthouze M, Giner M, Soulier JL, Rivail L, Sicsic S, Lezoualc'h F, Jockers R et al. Synthesis of specific bivalent probes that functionally interact with 5-HT(4) receptor dimers. J Med Chem 2007; 50: 4482-92.